Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Pre-Clinical
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014 7:14:10 AM
La Jolla Pharmaceutical Company (LJPC) Announces Positive Pre-Clinical Data For Oral Galectin-3 Inhibitor In Nonalcoholic Steatohepatitis (NASH) 7/15/2014 7:35:18 AM
Anavex Life Sciences Corp. (AVXL.OB) 3-71 Highly Effective And Disease-Modifying Against All Major Alzheimer's Hallmarks In Preclinical Disease Model 7/14/2014 6:09:38 AM
BrainStorm Cell Therapeutics Inc. Announces Publication Of Preclinical Multidose Study Of NurOwn 7/11/2014 10:19:27 AM
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014 6:06:33 AM
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014 10:30:11 AM
Nuvilex (NVLX) Scheduled To Begin Preclinical Studies In Early August 7/9/2014 10:28:19 AM
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014 10:46:07 AM
Dicerna Pharmaceuticals (DRNA) Release: Researchers Demonstrate Promise Of Dicerna Investigational Therapy In Preclinical Model Of Primary Hyperoxaluria Type 1 (PH1) 6/30/2014 8:35:03 AM
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014 7:19:18 AM
Flamel Technologies (FLML) Announces Positive Preclinical Results For Its Once-a-Week Formulation Of Exenatide 6/25/2014 11:31:03 AM
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Closes Transaction To Acquire International Rights To Synacthen® And Synacthen® Depot 6/23/2014 7:48:36 AM
Pieris Achieves Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 6/23/2014 8:51:22 AM
Galectin Therapeutics Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 Is Efficacious In Preclinical Model Of Fatty Liver Disease With Fibrosis 6/23/2014 7:30:41 AM
Success In Kadimastem’s First Pre-Clinical Trial For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 6/19/2014 10:03:18 AM
1234567
//-->